Following successful evaluation, Bayer has chosen the GenoMAGICTM platform to support its advanced molecular breeding program in several key crops Ness Ziona, Israel – (December 3, 2018) –NRGene, the worldwide leader in genomic analysis, announces a key milestone in its multi-year licensing agreement with Bayer for the use of GenoMAGICTM, a cloud-based big data analytics platform to support the company’s molecular breeding program within its Crop Science Division. Bayer has completed a one-year evaluation of GenoMAGIC and has tested its usability to compare genetic makeup and select the best candidates for molecular breeding. “We were most satisfied by the ability of NRGene’s integrated analytics platform to support our genomics-based, molecular breeding pipeline,” said Dr. Ruth Wagner, genome & marker design lead for Bayer’s Crop Science Division. “We are excited to broaden the use of GenoMAGIC to more of our key crops.” “The world food demand is constantly on the rise, and life sciences companies like Bayer play a major role in our future food security,” said Dr. Gil Ronen, CEO of NRGene. “We are grateful our cutting-edge big data, artificial intelligence tools can support research and breeding toward achieving that goal.” The licensing agreement was originally signed by Monsanto Company prior to its acquisition by Bayer. Bayer’s R&D pipeline encompasses a broad range of solutions to help farmers mitigate the complex challenges they face on the farm – whether caused by pests, disease or weather – while improving their productivity and environmental sustainability. GenoMAGICTM delivers greater breadth and depth to Bayer’s ability to discover traits, enhance genomes, and for genomic selection. About NRGene NRGene is a Genomics company that provides turn-key solutions to leading breeding companies. Using advanced algorithmics & extensive proprietary databases, we empower breeders to reach their full potential by achieving stronger and more productive yields in record time. NRGene’s tools have already been employed by some of the leading agribiotech companies worldwide, as well as the most influential research teams in academia. www.nrgene.com. Follow us: Twitter, LinkedIn, and Facebook.
Bayer has completed a year-long evaluation of NRGene's GenoMAGICTM data analytics platform, and expressed satisfaction with its ability to support the German company's genomics-based molecular breeding pipeline. Cloud-based GenoMAGICTM expands Bayer's ability to discover traits and to enhance genomes. The company is also working on integrating genomic information into other applications such as predictive analytics, machine learning and artificial intelligence. NRGene signed a licensing agreement with Monsanto prior to its acquisition by Bayer earlier this year.